The European Medicines Agency has recommended to the European Commission that Pandemrix, made by GlaxoSmithKline (GSK), be granted a licence for use across Europe, including the UK.

Another vaccine intended for use in the UK, made by Baxter, is still being considered by the European Medicines Agency.

The European Commission will probably rubber-stamp the decision on the GSK vaccine in the next few weeks.

GSK has not yet delivered stocks of its vaccine to the Government, a spokesman for the Department of Health said.

Some stocks of the Baxter vaccine have already arrived.